Scholarlink

<p>We report a rare case of spontaneous regression of primary hepatic diffuse large B-cell lymphoma (DLBCL) in an 89-year-old man. A 12&#xa0;cm solitary hepatic mass was found in the anterior and medial segments. Contrast-enhanced CT showed a hypovascular solid tumor. Serologic markers including hepatitis B virus, hepatitis C virus, human immunodeficiency virus, alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, carbohydrate antigen 19–9, and carcinoembryonic antigen were negative, but soluble interleukin-2 receptor was elevated. Ultrasound-guided liver biopsy confirmed DLBCL, and the diagnosis of primary hepatic lymphoma was established based on Caccamo’s criteria. The patient declined chemotherapy or radiotherapy due to age and preference, and was observed without treatment. Initially, the tumor grew slightly, but later imaging showed spontaneous regression without intervention. No recurrence or progression was observed during 15&#xa0;months of follow-up. The regression may have been triggered by an immune response, possibly induced by biopsy-related stimulation. Primary hepatic lymphoma is extremely rare, accounting for 0.07% of malignant liver tumors, and spontaneous regression of untreated DLBCL is exceedingly uncommon. This case highlights the potential role of immune-mediated mechanisms in spontaneous tumor regression and supports careful observation as a possible management strategy in select elderly patients with primary hepatic lymphoma.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A case of spontaneous regression of primary hepatic diffuse large B-cell lymphoma

  • 期刊论文

  • 发表日期：

    2025年11月21日

查看全文
  • Tomohiro Ida,
  • Hiroshi Takahashi,
  • Katsutoshi Sugimoto,
  • Tatsuya Kakegawa,
  • Hirohito Takeuchi,
  • Maki Tanigawa,
  • Toshitaka Nagao,
  • Takao Itoi

摘要

We report a rare case of spontaneous regression of primary hepatic diffuse large B-cell lymphoma (DLBCL) in an 89-year-old man. A 12 cm solitary hepatic mass was found in the anterior and medial segments. Contrast-enhanced CT showed a hypovascular solid tumor. Serologic markers including hepatitis B virus, hepatitis C virus, human immunodeficiency virus, alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, carbohydrate antigen 19–9, and carcinoembryonic antigen were negative, but soluble interleukin-2 receptor was elevated. Ultrasound-guided liver biopsy confirmed DLBCL, and the diagnosis of primary hepatic lymphoma was established based on Caccamo’s criteria. The patient declined chemotherapy or radiotherapy due to age and preference, and was observed without treatment. Initially, the tumor grew slightly, but later imaging showed spontaneous regression without intervention. No recurrence or progression was observed during 15 months of follow-up. The regression may have been triggered by an immune response, possibly induced by biopsy-related stimulation. Primary hepatic lymphoma is extremely rare, accounting for 0.07% of malignant liver tumors, and spontaneous regression of untreated DLBCL is exceedingly uncommon. This case highlights the potential role of immune-mediated mechanisms in spontaneous tumor regression and supports careful observation as a possible management strategy in select elderly patients with primary hepatic lymphoma.